SCHEMBL1926257

SCHEMBL1926257

CCCN(C(=O)c1ccc(OC)cc1)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.64
HPGD P15428 2/20 0.61
KDM4E B2RXH2 1/20 0.61
TSHR P16473 1/20 0.59
ACHE P22303 1/20 0.57
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
BACE1 P56817 1/20 0.54
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 2/20 0.50
ADRB2 P07550 1/20 0.50
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
PTGIR P43119 1/20 0.50
ADRA2C P18825 1/20 0.50
MEN1 O00255 1/20 0.48
LPAR1 Q92633 1/20 0.47
LPAR5 Q9H1C0 1/20 0.47
PTGES O14684 1/20 0.47
ALOX5 P09917 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9001626 0.86 ADRA2C (0.65) TRPM8HPGDTSHRACHENPC1
SCHEMBL4560242 0.86 NPC1 (0.60) HPGDKDM4ETSHRACHENPC1
SCHEMBL16125622 0.85 ALDH1A1 (0.53) TRPM8HPGDTSHRNPC1RAB9A
SCHEMBL1926940 0.85 TRPM8 (0.53) TRPM8HPGDKDM4ETSHRNPC1
SCHEMBL6570858 0.84 KDM4E (0.63) TRPM8HPGDKDM4ETSHRACHE
SCHEMBL1928093 0.83 PKM (0.54) HPGDTSHRNPC1RAB9AKMT2A
SCHEMBL1926647 0.82 ADRA2C (0.53) HPGDTSHRBACE1ALDH1A1ADRB2
SCHEMBL11226870 0.81 TSHR (0.65) HPGDKDM4ETSHRACHENPC1
SCHEMBL6981124 0.81 KDM4E (0.60) TRPM8HPGDKDM4ETSHRACHE
SCHEMBL16125625 0.81 ALDH1A1 (0.49) TRPM8HPGDACHEALDH1A1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763509-B1 ALPHA-HELICAL MIMETICS WALTER & ELIZA HALL INST MEDICAL RES (AU) 2018-02-21 EP disclosed
US-7956216-B2 Benzoyl urea derivatives mimicing BH3-only proteins, able to interact with a Bcl-2 protein THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2011-06-07 US disclosed
US-20080153802-A1 Alpha-helical mimetics THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2008-06-26 US disclosed
EP-1763509-A1 ALPHA-HELICAL MIMETICS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2007-03-21 EP disclosed
WO-2006002474-A1 ALPHA-HELICAL MIMETICS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153802-A1 Alpha-helical mimetics BID, BAX, BAD TRPM8 4686/4885HPGD 2366/4885KDM4E 3056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.